NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab

QR Code

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab

Alfredomaria Lurati, Luca Bertani, Mariagrazia Marrazza, Katia Angela Re, Daniela Bompane, Magda ScarpelliniRheumatology Unit, Fornaroli Hospital, Magenta, ItalyPurpose: The relationship between antiCD20 therapy with rituximab and the lymphocytes phenotype in patients with rheumatoid arthritis was i...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Re KA, Marrazza M, Bertani L, Lurati A, Scarpellini M, Bompane D
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2012
Sujets:	Medicine (General) R5-920
Accès en ligne:	https://doaj.org/article/c6faa4f926904747943482ce1ce7ba1c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
par: Lurati A, et autres
Publié: (2013)

Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
par: Lurati A, et autres
Publié: (2021)

Safety of etanercept in elderly subjects with rheumatoid arthritis
par: Alfredomaria Lurati, et autres
Publié: (2009)

Rituximab therapy in Greek patients with rheumatoid arthritis
par: Haralampos M Moutsopoulos, et autres
Publié: (2008)

Update on the use of rituximab for intractable rheumatoid arthritis
par: R John Looney
Publié: (2009)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
par: Ulusoy H, et autres
Publié: (2020)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
par: Joseph M Tuscano, et autres
Publié: (2009)

The macrophages in rheumatic diseases
par: Laria A, et autres
Publié: (2016)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
par: Benucci M, et autres
Publié: (2013)

Goals for rheumatoid arthritis: treating to target or treating to prevent?
par: Yang M, et autres
Publié: (2012)

Different T cells' distribution and activation degree of Th17 CD4+ cells in peripheral blood in patients with osteoarthritis, rheumatoid arthritis, and healthy donors: preliminary results of the MAGENTA CLICAO study
par: Lurati A, et autres
Publié: (2015)

Tender and swollen joint counts are poorly associated with disability in chikungunya arthritis compared to rheumatoid arthritis
par: Hugh Watson, et autres
Publié: (2021)

Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
par: Hasan E, et autres
Publié: (2012)

Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
par: Sook Yan Lee, et autres
Publié: (2021)

Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
par: M. del Carmen Larios-Forte, et autres
Publié: (2021)

Bone-sparing effects of rituximab and body composition analysis in a cohort of postmenopausal women affected by rheumatoid arthritis – retrospective study
par: Suhel Gabriele Al Khayyat, et autres
Publié: (2021)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
par: Peter BB Jones, et autres
Publié: (2010)

Osteosarcopenia in rheumatoid arthritis treated with glucocorticosteroids – essence, significance, consequences
par: Marcin Radkowski, et autres
Publié: (2020)

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNF&alpha; blocker failure
par: Kekow J, et autres
Publié: (2012)

Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results
par: Santos-Moreno P, et autres
Publié: (2020)

CLINICAL AND IMMUNOLOGICAL PARAMETERS IN EARLY RHEUMATOID ARTHRITIS
par: V. V. Sokolova, et autres
Publié: (2014)

Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry
par: Nobunori Takahashi, et autres
Publié: (2020)

Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
par: Ríos C, et autres
Publié: (2017)

Revealing the efficacy-toxicity relationship of Fuzi in treating rheumatoid arthritis by systems pharmacology
par: Wuwen Feng, et autres
Publié: (2021)

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
par: Borja Hernández-Breijo, et autres
Publié: (2021)

Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
par: Cutolo M, et autres
Publié: (2013)

Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.
par: Ceara E Walsh, et autres
Publié: (2011)

PREDICTION OF CLINICAL EFFICIENCY OF SIMVASTATIN TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
par: I. V. Shirinsky, et autres
Publié: (2014)

Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
par: Jianan Zhao, et autres
Publié: (2021)

STUDIES OF SEVERAL BLOOD CYTOKINES IN PATIENTS WITH RHEUMATOID ARTHRITIS: CLINICAL AND IMMUNOLOGAL INTERRRELATIONS
par: M. V. Pachkunova, et autres
Publié: (2014)

Baricitinib for the treatment of rheumatoid arthritis
par: Ivan Urits, et autres
Publié: (2020)

Management of Rheumatoid Arthritis: An Overview
par: Andrei-Flavius Radu, et autres
Publié: (2021)

The prevalence of rheumatoid arthritis in Spain
par: Lucía Silva-Fernández, et autres
Publié: (2020)

Rheumatoid arthritis: Disease or syndrome?
par: Jessica A Stanich, et autres
Publié: (2009)

Infliximab in the treatment of rheumatoid arthritis
par: A Perdriger
Publié: (2009)

Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
par: Bogdan Batko, et autres
Publié: (2018)

Mixed Cryoglobulinaemia Vasculitis Treated with Obinutuzumab in a Patient Allergic to Rituximab
par: Margarida Gaudencio, et autres
Publié: (2021)

Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up
par: Laria A, et autres
Publié: (2017)

Humoral Response to Microbial Biomarkers in Rheumatoid Arthritis Patients
par: Seyedesomaye Jasemi, et autres
Publié: (2021)

Cold-induced urticaria associated with type I cryoglobulinemia, successfully treated with rituximab
par: Leonie C. Stroet, MD, et autres
Publié: (2022)